DermTech: The First Noninvasive Gene Expression Test for Skin Cancer

article image
ARTICLE SUMMARY:

DermTech combines an easy-to-use noninvasive adhesive patch biopsy with a gene expression assay to increase the accuracy and decrease the invasiveness of current diagnostic methods that are based primarily on a subjective visual assessment.

Melanoma is the most deadly of skin cancers; it accounts for only 1% of skin cancer cases but causes the majority of deaths. 

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: